Presentation available January 10
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces UroShieldÂ® and PainShieldÂ® portable surface acoustic wave (SAW) ultrasonic therapy devices, today announced that it will be featured as a company presenter at the HC Wainwright BioConnect virtual conference to be held January 10-13, 2022.
Brian Murphy, President and CEO of NanoVibronix, will provide an overview of the company’s business during the presentation.
If you are an institutional investor and would like to listen to the company presentation, please click on the following link (www.hcwevents.com/bioconnect) to register for the conference.
Investors can listen to the NanoVibronix presentation online starting January 10 at 7 a.m. ET via the following link: https://journey.ct.events/view/1fb99e38-4b44-441c-9bbe-2941dd1583a8
The recording of the presentation will be available for 90 days from the start of the conference.
About NanoVibronix, Inc.
NanoVibronix, Inc. (NASDAQ: NAOV) is a medical device company headquartered in Elmsford, New York, with research and development activities in Nesher, Israel, focused on the development of medical devices using its patented technology of low intensity surface acoustic waves (SAW). The proprietary technology enables the creation of low frequency ultrasonic waves that can be used for a variety of medical applications, including disrupting biofilms and bacterial colonization, as well as relieving pain. The devices can be administered at home without the assistance of healthcare professionals. The company’s main products include PainShieldÂ® and UroShieldÂ®, which are portable devices suitable for home administration without the assistance of healthcare professionals. Additional information on NanoVibronix is ââavailable at: www.nanovibronix.com.
About HC Wainwright & Co.
HC Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advice and related services to public and private companies across multiple sectors and regions. HC Wainwright & Co. also provides research and sales and trading services to institutional investors. According to Sagient Research Systems, the HC Wainwright team is ranked as the No.1 Placement Agent in terms of CMPO (Confidential Takeover Bid), RD (Direct Registered Bid), and PIPE (Private Investment in Public Equities). ) carried out cumulatively since 1998.
For more information, visit HC Wainwright & Co. on the web at www.hcwco.com